U.S. Government Hits HIV Drug Manufacturer With Patent Complaint
The Department of Health and Human Services says Gilead Sciences is profiting off HIV prevention drugs patented by the U.S. government.
The Trump administration is suing drugmaker Gilead Sciences for patent infringement over its HIV prevention drugs.
Gilead Sciences manufactures Truvada and Descovy, two pre-exposure prophylaxis drugs, also known as PrEP. The Department of Health and Human Services is accusing the company of profiting billions of dollars off the HIV prevention drugs when the patents are actually owned by the government.
According to HHS, Gilead Sciences "repeatedly refused" to obtain licenses for use of those patents.
In a statement, HHS Secretary Alex Azar said while the department "recognizes Gilead's role" in selling the drugs to patients, it "must respect the U.S. patent system, the groundbreaking work by CDC researchers, and the substantial taxpayer contributions to the development of these drugs."
Gilead has previously faced criticism over the steep price of the drugs — around $20,000 a year.
Multiple media outlets say Gilead did not respond to requests for comment on the lawsuit. But in August, Gilead said it submitted petitions to the U.S. Patent and Trademark Office requesting a review of the patents granted to HHS, arguing that the patents for PrEP were "not valid."
An estimated 1.1 million people in the U.S. had HIV at the end of 2016, the most recent year for which this information is available.
The science and safety behind newly popular weight loss drugs
Today’s weight loss drugs pull from the science of diabetes treatments. Those have been proven for years to have fewer and less serious side effects.By Patrick Sison / AP
Amazon launches $5-a-month unlimited prescriptions for Prime members
The retail giant’s RxPass has a prescription list that includes more than 50 common medications.By Mark Lennihan / AP
Men And Women Given Differing Advice To Treat Heart Disease
Researchers found that heart disease in women has been overlooked and women are less likely than men to be prescribed medication to treat it.By Joe Raedle / Getty Images
Israel's new government sparks concern for the future of its democracy
Far-right changes to Israel's government has some experts and citizens concerned for the future rule of law in the country.By Reuters / AP
WHO says COVID remains an emergency but is in transition
The World Health Organization said there is still uncertainty in COVID-19's future, but the virus is at a "transition point."By Shutterstock
First Native American woman in space talks to reservation's students
Students on the Flathead Indian Reservation asked Nicole Mann questions as she was aboard the International Space Station.By NASA